Jinyu Bio-Technology Co (SHSE:600201) Accounts Payable & Accrued Expense : ¥624 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Jinyu Bio-Technology Co Accounts Payable & Accrued Expense?

Jinyu Bio-Technology Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥656 Mil) to Dec. 2023 (¥678 Mil) but then declined from Dec. 2023 (¥678 Mil) to Mar. 2024 (¥624 Mil).

Jinyu Bio-Technology Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥569 Mil) to Dec. 2022 (¥511 Mil) but then increased from Dec. 2022 (¥511 Mil) to Dec. 2023 (¥678 Mil).

Jinyu Bio-Technology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jinyu Bio-Technology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinyu Bio-Technology Co Accounts Payable & Accrued Expense Chart

Jinyu Bio-Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

450.24

589.90

569.09

510.87

677.65

Jinyu Bio-Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															481.30	623.60	656.12	677.65	623.94

Jinyu Bio-Technology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jinyu Bio-Technology Co (SHSE:600201) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jinyu Bio-Technology Co Ltd (SHSE:600201) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030

Website

http://www.jinyu.com.cn

Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.

Executives

Zhang Chong Yu	Director
Zhang Jing	Directors, senior managers
Yang Zhao	senior management
Li Rong	senior management
Zhang Zhan Fu	Supervisors
Wei Xue Feng	Director
Wang Yong Sheng	Directors, senior managers
Yin Song Tao	Directors, senior managers
Liu Guo Ying	Supervisors
Zhang Hong Mei	senior management
Wen Li Min	Director
Xu Xian Ming	Director
Xu Shi Jun	Director
Wang Xiu Hua	Director
Li Shu Jian	senior management

Jinyu Bio-Technology Co (SHSE:600201) Headlines

No Headlines